به جمع مشترکان مگیران بپیوندید!

تنها با پرداخت 70 هزارتومان حق اشتراک سالانه به متن مقالات دسترسی داشته باشید و 100 مقاله را بدون هزینه دیگری دریافت کنید.

برای پرداخت حق اشتراک اگر عضو هستید وارد شوید در غیر این صورت حساب کاربری جدید ایجاد کنید

عضویت

جستجوی مقالات مرتبط با کلیدواژه "microglia" در نشریات گروه "پزشکی"

  • Ali Rismanbaf, Khashayar Afshari, Nazgol-Sadat Haddadi, AhmadReza Dehpour, Hamed Shafaroodi

    Macrophages and glial activation contribute to the pathophysiology of spinal cord injury (SCI). Some preclinical studies have shown the anti-inflammatory effects of aripiprazole (ARP). In the current study, we evaluated the anti-inflammatory effects of ARP in a rat SCI model. Forty male Wistar rats underwent either T9 vertebra laminectomy or were used as a sham-operated group without laminectomy. There were four major groups in this study: a sham-operated, three treatments (normal saline [vehicle] control versus ARP 10 and 20 mg/kg/day for three days after surgery, first dose 30 minutes post-surgery) SCI groups. We evaluated locomotor scaling and neuropathic pain behavioral tests over 28 days. On Day 28, tissue samples were investigated for neuroinflammatory and histopathology changes through flow cytometry and ELISA. ARP (10 and 20 mg/kg/day, 3 days) treatment significantly reduced locomotors disability (P<0.01) and mechanical (P<0.01) and thermal allodynia (P<0.001) scores. Additionally, Levels of tumor necrosis factor (TNF)-α level and interleukin (IL)-10 were significantly altered in ARP-treated spinal cord tissues 28 days after SCI (P<0.01). Moreover, spinal cord tissue expression of M1 and M2 macrophages, as well as M1/M2 ratio, were reduced in ARP-treated SCI animals, concurrent with decreased M1 and increased M2 and M1/M2 in dorsal root ganglion (P<0.001). Our study indicates that ARP has therapeutic effects on SCI via the reduction of neuroinflammation and SCI sensory and locomotor abnormalities.

    Keywords: Aripiprazole, Spinal cord injury, Neuropathy, Neuroinflammation, Microglia, Macrophages
  • Zahra Nazari, Khadijeh Bahrebar, MohammadJafar Golalipour *
    Objective (s)

    Ecstasy is a popular recreational psychostimulant with side effects on the central nervous system. This study examined the corpus striatum tissue of adult rats that received ecstasy during the embryonic period for histological and molecular studies.

    Materials and Methods

    Rats were divided into control and ecstasy groups. The ecstasy group was given MDMA 15 mg/kg intraperitoneally twice daily at 8-hour intervals on days 7–15 of gestation. At the age of 15 weeks, adult offspring of both groups were examined for learning and memory study by the Morris water maze test. Then, ventral striatum tissue was harvested for TUNEL assay, Nissl staining, and real-time PCR for the expression of the GFAP and CD11b. 

    Results

    Ecstasy up-regulated the GFAP and CD11b expression in the striatum of offspring (*P˂0.05). Furthermore, the Morris water maze test showed that exposure to ecstasy significantly impaired learning and spatial memory (*P˂0.05). TUNEL assay results did not show any significant change in the number of apoptotic cells in the striatum tissue of ecstasy offspring compared with controls, while Nissl staining showed a significant decrease in the number of neurons in the ecstasy group (*P˂0.05).

    Conclusion

    Exposure to ecstasy during pregnancy causes long-lasting changes in brain regions underlying learning and memory, including the striatum, and impaired working memory in the offspring. In addition, these data provide the first evidence that exposure to ecstasy during the embryonic period causes a persistent change in the activity of microglial cells and the number of astrocyte cells in the striatum.

    Keywords: Astrocyte, Cell death, Corpus striatum, MDMA, Microglia
  • بهار خشکرودیان، محمد سیاح*، حمید غلامی پور بدیع
    زمینه و هدف

    رایج ترین اشکال بتا آمیلویید در مرحله اولیه بیماری آلزایمر اولیگومرهای بتاآمیلویید هستند که برای سلول های عصبی بسیار سمی هستند و می توانند عملکرد سیناپسی و حافظه را مختل کنند. از طرفی توانایی آن ها برای فعال کردن میکروگلیا ها بحث برانگیز است. لیگاندهای قوی و ضعیف گیرنده های شبه تول (TLR) می توانند میکروگلیاها را در ایجاد پروفایل سایتوکاینی و کموکاینی متفاوتی تحریک نمایند. در این مطالعه میزان بیان سیتوکاین اینترلوکین-6 و کموکاین پروتئین القاء شده با اینترفرون گاما- 10  (IP-10) از رده سلولی میکروگلیایی BV-2 در حضور و عدم حضور بتاآمیلویید مورد بررسی قرار گرفت.

    روش ها

    سلول های رده BV-2 در پلیت 24 خانه تحت درمان با دوزهای مختلف (0/1، 1 و 10 میکروگرم) مونوفسفوریل لیپید آ (MPL) و لیپوپلی ساکارید (LPS) به عنوان لیگاند گیرنده TLR4 و پم-3-سیس به عنوان لیگاند گیرنده TLR2 به مدت 24 ساعت قرار گرفتند. سپس محیط رویی جمع گردید و سلول ها با محیط حاوی یک میکرومول اولیگومر بتا آمیلویید به مدت 24 ساعت انکوبه شدند. بیان اینترلوکین-6 و IP-10 به روش الایزا در محیط رویی در شرایط حضور و عدم حضور بتاآمیلویید اندازه گیری شد.

    یافته ها

    مطالعه ما نشان داد که هر سه لیگاند در دوز 10 میکروگرم/میکرولیتر باعث ترشح معنی دار اینترلوکین-6 شدند و MPL در تمام دوزها دارای کمترین اثر بر ترشح اینترلوکین-6 از سلول هایBV-2  میکروگلیا بود. از طرفی پیش درمان سلول هایBV-2  با MPL به عنوان یک لیگاند ضعیف TLR4 باعث آزاد سازی مقدار قابل توجه کموکاین IP-10 از سلولهای BV-2 قبل از مواجه با بتاآمیلویید شد.

    نتیجه گیری

    می توان گفت با سوق دادن میکروگلیا ها برای ایجاد پروفایل پیش التهابی کمتر و ترشح کموکاینی بیشتر و احتمالا افزایش قدرت فاگوسیتوزی این سلول ها بتوان از رسوب بتا آمیلویید و در نهایت از پیشرفت بیماری آلزایمر جلوگیری کرد.

    کلید واژگان: بتاآمیلوئید, بیماری آلزایمر, گیرنده شبه تول, مونوفسفوریل لیپید آ, میکروگلیا ​​​​​​​
    Bahar Khoshkroodian, Mohammad Sayyah*, Hamid Gholami Pourbadie
    Background and aims

    Soluble amyloid beta (Aβ) oligomers are the most common forms of Aβ in early stage of Alzheimer disease (AD). They are highly toxic to the neurons, but their capability to activate microglia remains controversial. Synaptic function and memory performance are disrupted by soluble form of Aβ. Full and partial toll like receptor (TLR) ligands can stimulate microglia to produce different cytokine and chemokine profiles. This study was designed to investigate the expression of interlukin-6 (IL-6) as a cytokine and protein 10 interferon gamma (IP-10) as a chemokine from BV-2 microglia cell line in the presence and absence of Aβ.

    Methods

    The BV-2 cell line was cultured in a 24-well plate, treated for 24 h with different doses (0.1, 1, 10 µg) of Monophosphoryl lipid A (MPL), Lipopolysaccharide (LPS) as TLR4 ligands, and Pam3cys as a TLR2 ligand. Then supernatant was collected and cells were incubated with 1µM Aβ oligomer for 24 h. IL-6 and IP-10 expression was measured by ELISA in the supernatant before and after Aβ treatment.

    Results

    LPS and Pam3cys 10µg/µl induced a robust release of IL-6 from BV-2 microglia cells. However, MPL at all doses had a lowest effect on secretion of IL-6 from BV-2 microglia cells. On the other hand, pretreatment of BV-2 cells with MPL as a partial TLR4 ligand caused release of significant amount of IP-10 chemokine from BV-2 cells.

    Conclusion

    It can be said that priming microglia to produce less pro-inflammatory cytokines while showing higher chemokine or phagocytic activity leads to decrease in Aβ deposition and might prevent AD progression.

    Keywords: Beta amyloid, Alzheimer’s disease, Toll-like receptor, Monophosphoryl lipid A, Microglia
  • Xiao Yan Zhang, Xiao Cheng Zhang, Hai Yang Yu, Yun Wang, Jason Chen, Yang Wang, Li Yu, Guo Xin Zhu, Xiu Jing Cao, Sheng Hai Huang *
    Objective(s)

    To elucidate the mechanism of Respiratory Syncytial Virus (RSV) infection and central neuronal disease and to understand the role of microglia in neuronal injuries during RSV infection.

    Materials and Methods

    The effects of RSV and the cytokines produced by RSV-infected CHME-5 microglial cells on SY5Y neuronal cells were evaluated based on an in vitro Transwell coculture system. Five treatment groups were established in this study, including the normal control SY5Y group, RSV+SY5Y infection group, (cytokine+CHME-5)+SY5Y Transwell group, (RSV+CHME-5)+SY5Y Transwell group, and (RSV+cytokine+CHME-5)+SY5Y Transwell group. The morphological and physical alterations in SY5Y cells and their synapses were analyzed by confocal microscopy. The mRNA and protein expression levels of TLR3/RIG-I, as well as the expression of Hv1, in microglia were measured by qRT-PCR and Western blot assays. In addition, the apoptosis ratio of neuronal cells was determined by flow cytometry.

    Results

    RSV infection activated the protein expression of Hv1 protein in microglia in vitro (p <0.05), induced morphological changes in SY5Y cells, lengthened synapses (73.36±0.12 μm vs 38.10±0.11 μm), simultaneously activated TLR3 and RIG-I protein expression (p <0.05), upregulated the secretion of the inflammatory cytokines TNF-α, IL-6, and IL-8 (p <0.01), and increased the apoptosis rate of SY5Y cells (p <0.01).

    Conclusion

    The results demonstrate that RSV infection of microglia can induce SY5Y neuronal cell injury and stimulate apoptosis through inflammatory cytokine release.

    Keywords: Cytokines, In Vitro Techniques, Microglia, Neurons, Respiratory syncytial virus infections
  • Elham Namjoo, Mohammad Shekari, Aliyar Pirouzi, Hossein Forouzandeh*, Davod Khalafkhany, Abdolvahid Vahedi, Iraj Ahmadi
    Introduction

    Microglia, small glial cells, i.e. mesodermal in origin and found in the brain and spinal cord, play a key role in the maintenance of neurons and immune defense. Haloperidol, an antipsychotic drug, is used to treat numerous neurological and neurodegenerative disorders. Its mechanism is not understood; however, haloperidol may result in Wnt signaling pathway activation. This study aimed to activate the Wnt signaling pathway using haloperidol and determining the effect of GSK3 inhibition on the expression of TGFB, NT-3, and BDNF genes in cultured rat microglia. 

    Methods

    Microglia isolation was conducted, and the immunohistochemistry technique was performed to confirm microglia purity. The RNA extraction was followed by cDNA synthesis. Real-time RT-PCR was used to evaluate any significant changes in the expression level of these genes. 

    Results

    The three gene expressions in microglia were proportional to the different concentrations of the drug. More concentration of drugs resulted in higher levels of expression of these genes. Besides, the haloperidol did not affect the expression of the beta-actin gene as the reference gene. 

    Conclusion

    The obtained results supported the beneficial use of haloperidol in targeted microglia therapy. This study can be a breakthrough in neurology research.

    Keywords: Microglia, Haloperidol, TGFB, NT-3, BDNF
  • Yong Xiang Shi, Wei Shan Chen *
    Objective(s)

    The pathophysiology of neurodegenerative diseases is complicated, in which inflammatory reactions play a vital role. Microglia cells activation, an essential process of neuroinflammation, can produce neurotoxic molecules and neurotrophic factors, which aggravate inflammation and neuronal injury. Monascin, a major component of red yeast rice, is an azaphilonoid pigment with potential anti-inflammatory effects; however, the effects in central nervous system have not been evaluated. Our goal in this project was to explore the therapeutic effect and the underlying mechanism of Monascin, which may be via anti-inflammatory action.

    Materials and Methods

    We used lipopolysaccharide to induce BV-2 microglial cells in order to form an inflammation model in vitro. The anti-inflammatory effects of Monascin were measured by enzyme-linked immunosorbent assay (ELISA), real time-polymerase chain reaction (RT-PCR), Western Blot and Immunofluorescent staining.

    Results

    Our data indicated that inflammatory cytokines including interleukin-1β (IL-1β), IL-6, tumor necrosis factor-alpha (TNF-α) and nitric oxide were suppressed by Monascin treatment. Furthermore, the related pro-inflammatory genes were inhibited consistent with the results of ELISA assay. Western blotting results showed that the phosphorylation of nuclear factor kappa B (NF-κB/p65) was reduced by Monascin treatment may be through suppressing the activation of IκB. Furthermore, immunofluorescence staining showed that the translocation of NF-κB/p65 to the cellular nuclear was blockaded after Monascin treatment.

    Conclusion

    Taken together, Monascin exerts anti-inflammatory effect and suppressed microglia activation, which suggested its potential therapeutic effect for inflammation-related diseases.

    Keywords: BV-2, Inflammatory reaction, Microglia, Monascin, NF-κB, p65 pathway
  • Yan Tan, Si-Wei Tan, Bo-Ya Fan, Lei Li *, Yuan-Guo Zhou*
    Background
    Hemin is an important sterile component that induces a neuroinflammatory response after intracerebral hemorrhage, in which NLRP3 inflammasome activation has also proved to be involved. Although microglial activation acts as a key contributor in the neuroinflammatory response, the relationship between hemin and NLRP3 in microglia remains poorly understood.
    Objective
    To investigate whether or not hemin regulates microglia-mediated secondary injury through activating the NLRP3/caspase-1 signaling pathway in microglia.
    Methods
    In this study, N9 microglial cells were treated with hemin, and subsequently used to detect the production of caspase-1 p10 and NLRP3 inflammasome assembly. An ELISA was subsequently performed to measure the secretion of IL-1β.
    Results
    It was found that the production of activated caspase-1 was dose- and time-dependent with regards to hemin. Moreover, hemin was observed to be capable of inducing the assembly of the NLRP3 inflammasome without any increase in IL-1β. Similarly, the supernatant of hemin-treated primary microglial cells did not increase in IL-1β secretion. Furthermore, hemin-induced NLRP3 inflammasome activation did not significantly affect pyroptosis.
    Conclusion
    Hemin is a potential sterile danger signal molecule that can induce inflammasome activation without directly mediating inflammation damage on microglia.
    Keywords: Caspase-1, Hemin, Microglia, NLRP3 Inflammasome
  • Bahareh Amin, Reyhaneh Noorani, Bibi Marjan Razavi, Hossein Hosseinzadeh*
    Objective
    We examined the protective effects of ethanolic extract of Lippia citriodora (L. citriodora) on rats subjected to chronic constriction injury (CCI) of sciatic nerve and possible mechanisms of actions.
    Materials And Methods
    In this experimental study, the extract was administered 50, 100 and 200 mg/kg, Intraperitoneally (I.P) from the surgery time for 14 consecutive days. The changes in the spinal cord levels of apoptotic factors, microglia and astroglia markers during the time course of study were assessed by western blotting on days 3, 7 and 14 post-CCI.
    Results
    CCI rats developed neuropathy evident from a marked mechanical allodynia, cold allodynia and thermal hyperalgesia on days 3, 5, 7, 10 and 14 post-CCI. A significant increase in the levels of Iba (a marker of microglia activation) and Bax (a proapoptotic factor) was observed three days after nerve injury. The levels of Iba remained high on day 7. In contrast, there was no difference in glial fibrillary acidic protein (GFAP) contents between sham and CCI animals. Treatment with the extract significantly attenuated behavioral changes associated with neuropathy. Bax/Bcl-2 and Iba1 were decreased in CCI animals treated with the extract.
    Conclusion
    The results support the evidence that microglial activation and apoptosis are correlated with pain behaviors. It is suggested that anti-allodynic and anti-hyperalgesic effects, elicited by L. citriodora, might have some degrees of association with the inhibition of microglia activation and apoptotic pathways.
    Keywords: Apoptosis, Astroglia, Lippia, Microglia, Neuropathic Pain
  • رحیمه برگی، حسین سلمانی *، فرشته اصغر زاده یزدی، محمود حسینی
    مقدمه
    التهاب پاسخ فیزیولوژیکی سیستم ایمنی بر علیه محرک های آسیب رسان داخلی و خارجی است. با این وجود التهاب یک شمشیر دولبه بوده و اگر به درستی کنترل نشود می تواند مضر واقع شود. امروزه التهاب به عنوان عاملی بسیار مهم در پاتوفیزیولوژی بیماری های عصبی مورد توجه قرار گرفته است. التهاب عصبی می تواند ناشی از آسیب به خود بافت مغزی باشد و یا توسط التهاب محیطی القاء شود. این فرایند با فعال شدن میکروگلیاها، تحریک آستروسیت ها، آسیب به سد خونی مغزی و افزایش پس آیند در نفوذپذیری آن، ورود سلول های ایمنی محیطی به بافت مغزی، تولید بیش از حد سایتوکین ها، نیتریک اکساید، گونه های فعال اکسیژن و همچنین پروستاگلاندین ها و در نهایت با آسیب و مرگ نورون ها مشخص می شود. در این مطالعه، التهاب عصبی و نقش آن در پاتوفیزیولوژی بیماری های عصبی شامل بیماری پارکینسون، بیماری آلزایمر، بیماری هانتینگتون، افسردگی، اضطراب، صرع، شیزوفرنی و اوتیسم خلاصه شده و مورد بحث قرار گرفته است.
    نتیجه گیری
    با وجود اینکه التهاب نقش برجسته ای در رخداد بیماری های عصبی دارد ولی متاسفانه هنوز درمانی ایمن و کارآمد برای کنترل فرایندهای التهابی تنظیم نشده در مغز وجود ندارد. داروهایی که به طور معمول در کنترل التهاب استفاده می شوند به علت عدم نفوذ از سد خونی مغزی کمتر در مغز موثر واقع شده اند. از آنجایی که بسیاری از فرایندهای التهابی در مغز مفید می باشد کنترل التهاب به جای سرکوب التهاب روش کارآمدتری در راهبردهای درمانی خواهد بود.
    کلید واژگان: بیماری های انحطاط نورونی, میکروگلیا, بیماری های سیستم عصبی, التهاب
    Rahimeh Bargi, Hossein Salmani*, Fereshteh Asgharzadeh Yazdi, Mahmoud Hosseini
    Introduction
    Inflammation is a physiological response of immune system against internal and external harmful stimulus. However, inflammation is a double-edged sword and can be harmful if it is not properly controlled. Nowadays inflammation is considered as an important factor in the pathophysiology of neurological diseases. Neuroinflammation can be as a result of direct damage to the brain tissues or induced by systemic inflammation. This process is characterized by microglial activation, stimulates astrocytes, blood - brain barrier breakdown and consequent increase in the permeability, penetration of peripheral immune cells into parenchyma of the central nervous system, excessive production of cytokines, nitric oxide, reactive oxygen species as well as prostaglandins and finally, neuronal damage and death. In this study, neuroinflammation and its role in the pathophysiology of brain diseases, including Alzheimer's disease, Parkinson's disease, Huntington's disease, depression, anxiety, epilepsy, schizophrenia and autism are outlined and discussed.
    Conclusion
    Although inflammation has a prominent role in the pathogenesis of neurological diseases, there are no effective and safe treatments to control deregulated inflammatory processes in the brain. The medications usually used to control inflammation are not fully effective in the brain due to lack of BBB penetration. Since many inflammatory processes in the brain is beneficial, modulation of inflammatory responses will be a more efficient therapeutic approach than suppression of inflammatory processes.
    Keywords: Neurodegenerative Diseases, Microglia, Nervous System Diseases, Inflammationmation
  • Taraneh Moini, Zanjani, Seyed, Nasser Ostad, Farzaneh Labibi, Haleh Ameli, Nariman Mosaffa, Masoumeh Sabetkasaei*
    Background
    Evidence indicates that neuropathic pain pathogenesis is not confined to changes in the activity of neuronal systems but involves interactions between neurons, inflammatory immune and immune-like glial cells. Substances released from immune cells during inflammation play an important role in development and maintenance of neuropathic pain. It has been found that minocycline suppresses the development of neuropathic pain. Here, we evaluated the analgesic effect of minocycline in a chronic constriction injury (CCI) model of neuropathic pain in rat and assessed IL-6 concentration from cultured macrophage and microglia cells.
    Methods
    Male Wistar rat (n=6, 150-200 g) were divided into three different groups: 1) CCI뷨扲, 2) sham뷨扲, and 3) CCI皻. Minocycline (10, 20, and 40 mg/kg) was injected one hour before surgery and continued daily to day 14 post ligation. Von Frey filaments and acetone, as pain behavioral tests, were used for mechanical allodynia and cold allodynia, respectively. Experiments were performed on day 0 (before surgery) and days 1, 3, 5, 7, 10, and 14 post -injury. At day 14, rats were killed and monocyte-derived macrophage from right ventricle and microglia from lumbar part of the spinal cord were isolated and cultured in RPMI and Leibovitz's media, respectively. IL-6 concentration was evaluated in cell culture supernatant after 24 h.
    Results
    Minocycline (10, 20, and 40 mg/kg) attenuated pain behavior, and a decrease in IL-6 concentration was observed in immune cells compared to CCI vehicle-treated animals.
    Conclusion
    Minocycline reduced pain behavior and decreased IL-6 concentration in macrophage and microglial cells. lack;
    Background
    white'>drug discovery with H. lepturus scorpion venom.
    Keywords: Minocycline, Interleukin, 6, Macrophages, Microglia
  • Sasan Gazerani, Jalal Zaringhalam *, Homa Manaheji, Sahar Golabi
    Introduction
    Stimulation of peptidergic fibers activates microglia in the dorsal horn. Microglia activation causes fractalkine (FKN) release, a neuron-glia signal, which enhances pain. The transient vanilloid receptor 1 (TRPV1) mediates the release of neuropeptides, which can subsequently activate glia. TRPV1 and TRPV2 are generally expressed on C and Aδ fibers, respectively. Expression of both proteins is upregulated during inflammation, but expression of TRPV3 after induction of inflammation is unclear.
    Methods
    Adult male Wistar rats were used in all experiments. Arthritis was induced in them by single subcutaneous injection of complete Freund’s adjuvant (CFA) in their right hindpaws. Resiniferatoxin (RTX) was used to eliminate peptidergic fibers. We examined the relation between FKN and TRPV3 expression by administration of anti-FKN antibody.
    Results
    Our study findings indicated that 1) spinal TRPV3 was mostly expressed on nonpeptidergic fibers, 2) expression of spinal TRPV3 increased following inflammation, 3) elimination of peptidergic fibers decreased spinal TRPV3 expression, 4) alteration of hyperalgesia was compatible with TRPV3 changes in RTX-treated rat, and 5) anti-FKN antibody reduced spinal TRPV3 expression.
    Conclusion
    It seems that the hyperalgesia variation during different phases of CFA-induced arthritis correlates with spinal TRPV3 expression variation on peptidergic fibers. Moreover, spinal microglial activation during CFA inflammation is involved in TRPV3 expression changes via FKN signaling.
    Keywords: Hyperalgesia, TRPV3, Microglia, Fractalkine
  • Song Liu*, Zhonghua Wang, Bo Xu, Kui Chen, Jinyuan Sun, Lianping Ren
    Objective(s)
    Intermittent hypoxia (IH), caused by obstructive sleep apnea (OSA), could cause hippocampus or neuron damage through multiple signaling pathways, while the underlying mechanisms are still unclear. Thus, the present study aimed to explore the effect of IH on the biological functions of microglia cells.
    Materials And Methods
    Cell proliferation of BV2 cells after exposure to IH were observed by MTT assay and then DNA damage was detected by comet assay. RNA-sequencing assay was performed in cells under IH condition and normal conditions to find out the differentially expressed genes, which were further confirmed by reverse transcriptase polymerase chain reaction (RT-PCR) and Western blot assay.
    Results
    As results, IH inhibited the proliferation of BV2 cells, as well as caused DNA damage. RNA-sequencing assay revealed 4 differentially expressed genes (p21, Cyclin D1, Cyclin E2, and Gadd45α) which were associated with the network of P53 signaling pathways in BV2 cells, among which, p21 and Gadd45α were dramatically increased while Cyclin D1 and Cyclin E2 were both decreased significantly. Moreover, inflammatory factors including IL-6, TNF-α and iNOS were significantly up-regulated in microglia cells under IH conditions for 8 hr.
    Conclusion
    Our results indicated that IH could inhibit cyclin D1 and cyclin E2 expression via initiating multiple P53 pathways, which further blocked cell cycle transition and attenuated proliferative capability of BV2 cells. Meanwhile, IH activated inflammation reactions in BV2 cells. Present study elaborate the effects of IH on biological functions of microglia and provide theoretical foundation for further study on new therapy methods for OSA.
    Keywords: Inflammatory cytokine, Intermittent hypoxia, Microglia, P53 signaling pathways
  • Mahmoud Hassani, Farzaneh Sabouni, Solaleh Emamgholipour, Mohammad Hessam Rafiee, Mohammad-Sadegh Fallah, Shah-Sanam Abbasi, Mohammad Ansari
    Background
    Recently, much attention has been directed towards considering activated microgelial cells as putative targets for treatment of neurological disorders. MigriHeal® as a novel herbal remedy was introduced for the treatment of migraine headaches. The previous researches has shown that MigriHeal® extracts can decrease NO in an in vitro inflammatory model. The aim of this study was to investigate the effect of MigriHeal® on NO generation from LPS- stimulated microglia cells.
    Materials And Methods
    Neonatal rat primary microglial cells were isolated from the mixed glial cultures and the purity of the cultures was determined by immunocytochemistry. Microglial cells were pretreated with Migri-Heal® and activated by 1μg/ml LPS. Subsequently, NO levels in the culture supernatants were measured by a griess reaction. Our results showed that Migri-Heal® 50μg/ml significantly reduced NO level in inflamed microglia in a dose-dependent manner.
    Results
    The results showed that different concentrations of Migri-Heal® had no prominent effect on cell viability in presence of LPS as compared with the control group. In addition, the pretreatment of microglia cells with Migri-Heal® can prevent from a morphological changes of the cells into the round and phagocytic shape.
    Conclusion
    Our study demonstrated that MigriHeal® might have NO scavenging properties. Integrative studies are warranted to uncover the novel pharmacological insights of this herbal remedy as an putative therapeutic approach against diseases - associated with inflammation.
    Keywords: inflammation, microglia, Migri-Heal®, nitric oxide
  • Soraya Abbasi Habashi *, Farzaneh Sabouni, Ali Moghimi, Saeed Ansari Majd
    Background
    Microglial cells act as the sentinel of the central nervous system. They are involved in neuroprotection but are highly implicated in neurodegeneration of the aging brain. When over-activated, microglia release pro-inflammatory factors, such as nitric oxide (NO) and cytokines, which are critical in eliciting neuroinflammatory responses associated with neurodegenerative diseases. This study examined whether bromelain, the pineapple-derived extract, may exert an anti-inflammatory effect in primary microglia and may be neuroprotective by regulating microglial activation.
    Methods
    Following the isolation of neonatal rat primary microglial cells, the activation profile of microglia was investigated by studying the effects of bromelain (5, 10, 20, and 30 µg/ml) on the levels of NO, inducible nitric oxide synthase (iNOS), and nuclear factor kappa B (NF-κB) in microglia treated with lipopolysaccharide (LPS) (1 µg/ml). Data were analyzed using Student's t-test. P values less than 0.05 were considered to be statistically significant, compared with the LPS-treated group without bromelain.
    Results
    Results showed that pretreatment of rat primary microglia with bromelain, decreased the production of NO induced by LPS (1 µg/ml) treatment in a dose-dependent manner. Bromelain (30 µg/ml) also significantly reduced the expression of iNOS at mRNA level and NF-κB at protein level. Moreover, the study of mitochondrial activity in microglia indicated that bromelain had no cytotoxicity at any of the applied doses, suggesting that the anti-inflammatory effects of bromelain are not due to cell death.
    Conclusion
    Bromelain can be of potential use as an agent for alleviation of symptoms in neurodegenerative diseases.
    Keywords: Microglia, Nitric oxide, NF, kappa B, Neuroimmunomodulation, Ananas
  • آزاده سجادیان، مریم جعفریان، بابک خدایی، شاهین محمدصادقی، امیر قائمی*
    مقدمه
    توانایی القای پرتوانی به سلول های سوماتیک با استفاده از فاکتورهای برنامه ریزی مجدد، فرصتی جهت اکتشاف دارویی و سلول درمانی است. سلول های بنیادی پرتوان القایی توانایی تمایز به انواع سلول ها نظیر سلول های عصبی و گلیال را دارند. آستروسیت ها، سلول های گلیال اصلی سیستم عصبی مرکزی هستند که با تنظیم یون‏های خارج سلولی و انتقال دهنده های عصبی، تغذیه و حمایت از نورون ها و تعدیل عملکرد سلول های میکروگلیای فعال شده در مغز نقش حیاتی ایفا می کنند. فعالیت بیش از حد سلول های میکروگلیا می تواند منجر به التهاب مغزی و پس از آن مستعد شدن به حملات تشنجی شود.
    فرضیه: سال‏هاست که پیوند سلول‏های بنیادی جنینی به منظور پیشگیری از حمله تشنجی در صرع مورد آزمایش قرار گرفته است. این مطالعات نشان داد که سلول های بالغ گرفته شده از بیمار توانایی تبدیل به مرحله رویانی و تبدیل به سلول های بنیادی پرتوان، با استفاده از برخی فاکتورهای رونویسی مانند Oct4، Sox2، Nanog، Rex1، Klf، c-Myc و LIN28 را دارا می‏باشند. بر این اساس سلول های فیبروبلاست گرفته شده از بیمار مصروع می توانند مجددا برنامه ریزی شده و به مرحله جنینی باز گردانده شوند. سلول های پرتوان حاصله که نسبت به خود بیمار ایزوژنیک هستند توانایی تمایز به نورون ها و سلول های گلیال را در شرایط مناسب کشت دارند. در مطالعات گذشته توجه بیشتری به نورون‏ها نسبت به آستروسیت ها در درمان با سلول‏های بنیادی جنینی صورت گرفته است. آستروسیت ها از طریق ترشح عوامل نوروتروفیک نظیر GDNF عملکردهای مختلف سلول های میکروگلیال نظیر تکثیر سلول، مهاجرت و چسبندگی سلولی را تنظیم می‏کنند و همچنین قادر به کاهش تاثیرات مخرب سلول های میکروگلیال نظیر التهاب عصبی هستند.
    نتیجه گیری
    در این فرضیه، ما یک سیستم برنامه ریزی مجدد برای تولید آسترویت های عملکردی از سلول های بنیادی پرتوان انسانی در حضور فاکتورهای رشد نورونی را پیشنهاد می کنیم. فرضیه ما این است که این سلول‏ها ممکن است با کاهش التهاب عصبی ایجاد شده توسط سلول‏های میکروگلیا، وقوع تشنج را کاهش دهند. سلول های مجدد برنامه ریزی شده، می توانند جهت سلول درمانی در صرع استفاده شوند.
    کلید واژگان: آستروسیت, تشنج, صرع, سلول های میکروگلیا, سلول های بنیادی پرتوان القایی
    Azadeh Sajadian, Maryam Jafarian, Babak Khodaie, Shahin Mohammad Sadeghi, Amir Ghaemi*
    Introduction
    The ability to induce pluripotency in somatic cells by reprogramming factors offers new opportunities for drug discovery and cell therapy. Induced pluripotent stem cells have the potential to differentiate to various cell types, such as neural and glial cells. Astrocytes, the major glial cells of the central nervous system, play an important role in the function of the brain by regulating of extracellular ions and neurotransmitters, feeding and protection of neurons as well as modulating the activity of microglia. Microglia over-activation can be resulted in brain inflammation with subsequent susceptibility to epileptic seizures. Hypothesis: For many years, embryonic Stem cell transplantation has been examined to prevent seizure attacks in epilepsy. These studies have indicated that adult cells from patient have the ability to be transformed to embryonic stage and convert to a pluripotent stem cell by using some Transcription factors (such as Oct4, Sox2, Nanog, Rex1, Klf, c-Myc and LIN28). Accordingly, fibroblasts from an epileptic have also been reprogrammed to embryonic stage. The resulting iPS cells are isogenic to patient and are able to transform to neurons or glia in a suitable culture condition. Previous studies on ES cell therapy have focused more on neurons than astrocytes. Astrocytes, by secretion of glial cell-derived neurotrophic factor, not only regulate the different microglial activities, such as proliferation, migration and cell adhesion, but can also reduce destructive effects of microglia.
    Conclusion
    In this hypothesis, we suggest a reprogramming system for generating functional astrocyte from human pluripotent stem cell in the presence of neural growth factors. We hypothesize that these cells might reduce neuroinflammation induced by microglia and subsequent susceptibility to seizure. The reprogrammed cells could be used in cell replacement therapy of epilepsy.
    Keywords: Astrocytes, Seizures, Epilepsy, Microglia, Induced Pluripotent Stem Cells
  • علیرضا عبدانی پور، تقی طریحی، طاهر طاهری، هادی کاظمی
    زمینه
    درک فرآیندهای فعال شدن سیستم ایمنی بدن و فعال سازی ثانویه سلول های میکروگلیال پس از ضایعه نخاعی.
    مواد و روش ها
    مطالعه کمی تراکم سلول های ED-1 مثبت، سلول گلیال و اندازه حفره ایجاد شده در موش های ضایعه نخاعی درمان نشده در طی روز های 1، 2، 4، هفته اول، دوم، سوم و چهارم پس از ضایعه انجام شد.
    یافته ها
    نتایج حاصل از شمارش سلول های گلیال در 4900 میکرمتر از طناب نخاعی اسیب دیده افزایش معنی داری را در درصد تراکم این سلول ها در روز دوم بعد از ضایعه نسبت به سایر روز ها نشان داد. این در حالی است که سلول های ED-1 مثبت (نشانگر سلول های مونوسیتی و فاگوسیت) در حدود (15/23 درصد) بودند. همچنین ارزیابی درصد حفره ایجاد شده اختلاف معنی داری را بین هفته سوم و چهارم بعد از ضایعه نخاعی نشان داد.
    نتیجه گیری
    این یافته ها نشان می دهد که در طی آسیب طناب نخاعی، پاسخ سیستم ایمنی بشکل چند مرحله ای دیده می شود که عبارتند از پاسخ سلولی، فعالیت ماکروفاژها و میکروفاژ ها، تراکم سلول های گلیال و ایجاد حفره درنخاع. درک بهتر روند التهابی در مرحله حاد ضایعه نخاعی، امکان بهینه سازی مراحل درمان را امکان پذیر می سازد.
    کلید واژگان: ضایعه نخاعی, التهاب, میکروگلیا, ماکروفاژ
    Alireza Abdanipour, Taki Tiraihi *, Taher Taheri, Hadi Kazemi
    Background
    The present study was designed to evaluate the secondary microglial activation processes after spinal cord injury (SCI).
    Methods
    A quantitative histological study was performed to determine ED-1 positive cells, glial cell density, and cavitation size in untreated SCI rats at days 1, 2, and 4, and weeks 1, 2, 3, and 4.
    Results
    The results of glial cell quantification along the 4900-µm long injured spinal cord showed a significant increase in glial cell density percentage at day 2 as compared to other days. Whereas the highest increase in ED-1 immunoreactive cells (monocyte/phagocyte marker in rats) was observed at day 2 (23.15%) post-injury. Evaluation of cavity percentage showed a significant difference between weeks 3 and 4 post-injury groups.
    Conclusions
    This study provides a new insight into the multiphase immune response to SCI, including cellular inflammation, macrophages/microglia activation, glial cell density, and cavitation. Better understanding of the inflammatory processes associated with acute SCI would permit the development of better therapeutic strategies.
    Keywords: Spinal cord injuries, Inflammation, Microglia, Macrophages
  • Xiao, Qiao Dong, Quan Du, Wen, Hua Yu, Zu, Yong Zhang, Qiang Zhu, Zhi, Hao Che*, Feng Chen, Hao Wang, Jun Chen
    Oxymatrine, a potent monosomic alkaloid extracted from Chinese herb Sophora japonica (Sophora flavescens Ait.). possesses anti-inflammatory activittyes. This study was designed to investigate the effects of oxymatrine on nuclear factor–kappa B (NF-κB) and mitogen-activated protein kinase (MAPK)-dependent inflammatory responses in lipopolysaccharide (LPS)-activated microglia. In this paper, BV2 microglia were pretreated with different concentrations of oxymatrine (1, 10 and 20 μg/mL) for 30 min as followed by stimulation with LPS (1 µg/mL) for different times (30 min, 1 h, 3 h, and 6 h). Concentrations of nitric oxide (NO), prostaglandin E2 (PGE2), tumor necrosis factor-alpha (TNF-α), interleukin-1beta (IL-1β) and interleukin-6 (IL-6) in supernatant, mRNA levels of inducible nitric oxide synthase (iNOS) and cyclooxygenase-2 (COX-2), cytosolic inhibitor of kappa B-alpha (I-κBα) and phospho-I-κBα and nuclear p65 protein levels, and the phosphorylations of MAPK molecules such as extracellular-signal-regulated kinase (ERK) 1/2, p38 MAPK and c-Jun N-terminal kinase (JNK) were determined. It was shown that oxymatrine inhibited the productions of NO, PGE2, TNF-α, IL-1β and IL-6, attenuated the mRNA levels of iNOS and COX-2, suppressed the phosphorylation of I-κBα in cytosol, decreased the nuclear levels of p65, and also blocked ERK, p38 and JNK pathway in LPS-stimulated BV2 microglial cells in a dose-dependent manner. According to the results; It is suggested that oxymatrine may attenuate inflammatory responses of microglia and could be potentially useful in modulation of inflammatory status in the brain disorders.
    Keywords: Microglia, Oxymatrine, Nuclear factor kappa, B, Mitogen, activated protein kinase, Inflammation
  • بنفشه امیراصلانی، فرزانه صابونی، شاه صنم عباسی، حبیب الله ناظم، محمد صادق ثابت
    سابقه پژوهش: التهاب عصبی به عنوان مهمترین نتیجه فعالیت سلولهای میکروگلیا، یک فاکتور مهم برای پیشرفت بیماری های نورودژنراتیو از جمله بیماری آلزایمر و بیماری پارکینسون می باشد. سلولهای میکروگلیا به عنوان اولین خط دفاعی در سیستم عصبی مرکزی، منبعی از فاکتورهای نوروتوکسیک از جمله نیتریک اکساید- یک رادیکال آزاد که در مرگ سلولهای نورونی شرکت می کند- هستند. هدف از انجام این مطالعه، مهار تولید نیتریک اکساید در سلولهای میکروگلیای فعال در جهت کاهش آسیبهای نورولوژیکی که می تواند سیستم عصبی مرکزی را تهدید نماید، می باشد.
    روش کار
    مدل این ویترو کشت سلولی مغز موش های صحرایی تازه متولد شده برای بررسی اثر بتائین بر رهایش نیتریک اکساید القاء شده توسط لیپوپلی ساکارید مورد استفاده قرار گرفت. به طور خلاصه سلولهای پرایمری میکروگلیا توسط لیپو پلی ساکارید تحریک شده و بعد از 2 دقیقه با بتائین تیمار گردیدند. تولید نیتریک اکساید توسط روش گریس بررسی شد در حالیکه فعالیت متابولیکی سلولها با استفاده از روش MTT تعیین گردید.
    نتایج
    مشاهدات ما نشان دادند که آزاد شدن نیتریک اکساید القاء شده توسط لیپو پلی ساکارید با استفاده از بتائین کاهش یافت که پیشنهاد کننده این است که این ترکیب ممکن است رهاشدن نیتریک اکساید را مهار نماید. تاثیر بتائین بر تولید نیتریک اکساید در سلولهای میکروگلیای ملتهب پس از 24 ساعت، وابسته به دوز بوده است. به این معنی که سلولهای میکروگلیایی که با غلظت های بالاتربتائین تیمار شده بودند، مقادیر کمتری نیتریک اکساید آزاد نمودند. همچنین مشاهدات ما نشان دادند که بتائین هیچ اثر توکسیکی بر سلولهای میکروگلیا ندارد.
    نتیجه گیری
    بتائین بر آزاد شدن نیتریک اکساید در سلولهای میکروگلیای ملتهب اثر مهاری دارد و ممکن است به عنوان یک ترکیب درمانی موثر برای کنترل بیماری های نورولوژیکی مطرح باشد.
    کلید واژگان: بتائین, لیپو پلی ساکارید, نیتریک اکساید, میکروگلیا
    Banafsheh Amiraslani, Farzaneh Sabouni, Shahsanam Abbasi, Habiballah Nazem, Mohammadsadegh Sabet
    Background
    Neuroinflammation, as a major outcome of microglia activation, is an important factor for progression of neurodegenerative disorders including Alzheimer's disease and Parkinson's disease. Microglial cells, as the first-line defense in the central nervous system, act as a source of neurotoxic factors such as nitric oxide (NO), a free radical which is involved in neuronal cell death. The aim of this study was to inhibit production of NO in activated microglial cells in order to decrease neurological damages that threat the central nervous system.
    Methods
    An in vitro model of a newborn rat brain cell culture was used to examine the effect of betaine on the release of NO induced by lipopolysaccharide (LPS). Briefly, primary microglial cells were stimulated by LPS and after 2 minutes, they were treated by different concentrations of betaine. The production of NO was assessed by the Griess assay while cell viability was determined by the MTT assay.
    Results
    Our investigations indicated that LPS-induced NO release was attenuated by betaine, suggesting that this compound might inhibit NO release. The effects of betaine on NO production in activated microglial cells after 24 h were "dose-dependent". It means that microglial cells which were treated with higher concentrations of betaine, released lowers amount of NO. Also our observations showed that betaine compound has no toxic effect on microglial cells.
    Conclusion
    Betaine has an inhibitory effect on NO release in activated microglial cells and may be an effective therapeutic component to control neurological disorders.
    Keywords: Betaine, Lipopolysaccharides (LPS), Nitric oxide (NO), Microglia
نکته
  • نتایج بر اساس تاریخ انتشار مرتب شده‌اند.
  • کلیدواژه مورد نظر شما تنها در فیلد کلیدواژگان مقالات جستجو شده‌است. به منظور حذف نتایج غیر مرتبط، جستجو تنها در مقالات مجلاتی انجام شده که با مجله ماخذ هم موضوع هستند.
  • در صورتی که می‌خواهید جستجو را در همه موضوعات و با شرایط دیگر تکرار کنید به صفحه جستجوی پیشرفته مجلات مراجعه کنید.
درخواست پشتیبانی - گزارش اشکال